Emerging technologies are shaping antibody and protein engineering: Cellecta introduced DriverMap scAIR kits enabling detailed T and B cell receptor sequencing at single-cell resolution without specialized hardware. PROTEUS platform provides protein evolution in mammalian cells using virus-like vesicles for enhanced selection and mutagenesis. Dana Farber and Stanford patented novel molecular glue degraders targeting kinase proteins for cancer therapy. These platforms promise to accelerate development of precision therapies and diagnostics.